Calgary Parkinson Research Initiative (CaPRI)
Summary
CaPRI is an observational study over a five-year period. The purpose of this study is to create a Registry and Database that furthers our understanding about Parkinson’s disease (PD) and related movement disorders. The information collected will help doctors, researchers, and patients better understand how PD affects patients over time and also enable researchers to develop tests to diagnose and improve treatments for people with PD. CaPRI also aims to facilitate contact between ongoing research studies and participants who wish to contribute to the development and improvement of treatments for PD. Recently, CaPRI has partnered with the Canadian Open Parkinson Network (C-OPN) to expand its research potential Canada wide.
Eligibility
Eligible gender: Male, Female, Transgender, Other
Eligible ages: 18 to 100
Accepts healthy participants: Yes
Inclusion criteria:
1. Patients diagnosed with Parkinson's disease or Parkinson Plus Syndrome of any age
2. Healthy controls aged 18 years and over
Exclusion criteria:
1. There are no exclusion criteria for patients with PD or Parkinson Plus Syndromes in this study
2. Healthy controls cannot have a diagnosis of any neurodegenerative disorder
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Parisa Alizadeh p: 403-210-7542 e: parisa.alizadeh@ucalgary.ca
Principal investigator:
Davide Martino
Clinical trial:
No
REB-ID:
REB16-0545